InvestorsHub Logo
Followers 53
Posts 4603
Boards Moderated 0
Alias Born 07/04/2012

Re: None

Sunday, 08/03/2014 11:56:21 AM

Sunday, August 03, 2014 11:56:21 AM

Post# of 3683
Looks like we are going to get a failed study.... I sure was sucked in by Gil and his speeches...So were many others, just looking for an exit above buying price. Should get it on end of enrollment.

Can tell all, even if they show and or announce efficacy, it is worthless. First, if it were strong and explosive enough, we would have heard about it. So they way the testing is set up, it may or may not work and proof is difficult to show. Nothing has came from this company since April. Who knows what they have or have not worked on.

They certainly did not deserve huge raises, extra shares, etc... based on performance, which is nothing ! Really, in 15 years, what have they done, license another persons cells and failed at trials with them..

Back to stroke, even if you hear efficacy... sell on the news and be thrilled to do it. Any efficacy would be based on spleen (not shrinking from the cells).. if that is the case, MSC's would work too and any of the 20 plus cell companies will beat ATHX to the market.